March 2009 Volume 12 Number 1, pp 1 - 103
---------------------------------------------------------------------
Web Focus on Prostate Cancer
The Asian Journal of Andrology is proud to present a collection of
articles that outlines the current basic and clinical understanding
of prostate cancer. Alongside this web focus, the accompanying
special feature highlights the recent advances in the field and
identifies the potential for filling the gaps in our understanding.
Access the Web Focus on Prostate Cancer and the special feature today!
http://links.ealert.nature.com/ctt?kn=8&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
---------------------------------------------------------------------
Articles for Prostate Cancer and Prostatic Diseases are published
online ahead of print through Advance Online Publication (AOP),
meaning that the latest research reaches you in the timeliest way
possible. Check http://links.ealert.nature.com/ctt?kn=67&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0 each
week to make sure that you are not left behind.
----------------------
EDITORIAL
----------------------
Report from Durham
J Moul
http://links.ealert.nature.com/ctt?kn=84&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
----------------------
RESEARCH HIGHLIGHTS
----------------------
Prostate News
http://links.ealert.nature.com/ctt?kn=78&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
----------------------
REVIEWS
----------------------
HIV and prostate cancer: a systematic review of the literature
J Silberstein, T Downs, C Lakin and C J Kane
Abstract: http://links.ealert.nature.com/ctt?kn=43&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=98&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Prostate cancer chemotherapy in the era of targeted therapy
A Michael, K Syrigos and H Pandha
Abstract: http://links.ealert.nature.com/ctt?kn=103&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=90&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
Prostatic fluid electrolyte composition for the screening of prostate cancer:
a potential solution to a major problem
L C Costello and R B Franklin
Abstract: http://links.ealert.nature.com/ctt?kn=45&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=69&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines
M St John Floyd, S J Teahan, J M Fitzpatrick and R W G Watson
Abstract: http://links.ealert.nature.com/ctt?kn=57&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=29&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP
gene downregulation
Y Nakano, V Bilim, K Yuuki, A Muto, T Kato, A Nagaoka and Y Tomita
Abstract: http://links.ealert.nature.com/ctt?kn=1&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=94&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate
cancer xenografts
K Welen, K Jennbacken, T Tesan and J-E Damber
Abstract: http://links.ealert.nature.com/ctt?kn=51&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=47&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a
decrease in PSA?
D Connolly, A Black, L J Murray, T Nambirajan, P F Keane and A Gavin
Abstract: http://links.ealert.nature.com/ctt?kn=46&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=63&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Incidence of prostate cancer in male breast cancer patients: a risk factor for
prostate cancer screening
U J Lee and J S Jones
Abstract: http://links.ealert.nature.com/ctt?kn=34&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=79&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Probability of finding T1a and T1b (Incidental) prostate cancer during TURP has
decreased in the PSA era
J S Jones, H W Follis and J R Johnson
Abstract: http://links.ealert.nature.com/ctt?kn=97&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=32&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Biochemical relapse-free survival in 400 patients treated with I-125 prostate
brachytherapy: the Guildford experience
J P Nobes, I G Wells, S J Khaksar, J F Money-Kyrle, R W Laing and S E M Langley
Abstract: http://links.ealert.nature.com/ctt?kn=75&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=26&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Distress and social dysfunction following prostate cancer treatment: a
longitudinal cross-cultural comparison of Japanese and American men
S Namiki, L Kwan, M Kagawa-Singer, A Terai, T Satoh, S Baba, Y Arai and M S Litwin
Abstract: http://links.ealert.nature.com/ctt?kn=108&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=22&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Quality of life in patients with prostate cancer: development and application of
a hybrid assessment method
P C Stone, R F Murphy, H E Matar and M Q Almerie
Abstract: http://links.ealert.nature.com/ctt?kn=105&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=7&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Does presence of prostate cancer affect serum testosterone levels in clinically
localized prostate cancer patients?
T Imamoto, H Suzuki, M Yano, K Kawamura, N Kamiya, K Araki, A Komiya, Y Naya,
T Shiraishi and T Ichikawa
Abstract: http://links.ealert.nature.com/ctt?kn=38&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=48&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin
acetate in patients with prostate cancer in Europe
U W Tunn and K Wiedey
Abstract: http://links.ealert.nature.com/ctt?kn=54&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=92&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
The relationship of body mass index and serum testosterone with disease outcomes
in men with castration-resistant metastatic prostate cancer
A J Armstrong, S Halabi, R de Wit, I F Tannock and M Eisenberger
Abstract: http://links.ealert.nature.com/ctt?kn=104&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=99&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Prognostic significance of disordered calcium metabolism in hormone-refractory
prostate cancer patients with metastatic bone disease
M Tucci, A Mosca, G Lamanna, F Porpiglia, M Terzolo, F Vana, C Cracco, L Russo,
G Gorzegno, M Tampellini, M Torta, G Reimondo, M Poggio, R M Scarpa, A Angeli,
L Dogliotti and A Berruti
Abstract: http://links.ealert.nature.com/ctt?kn=21&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=6&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
----------------------
CASE REPORT
----------------------
Partial androgen suppression consequent to increased secretion of adrenal androgens
in a patient with prostate cancer treated with long-acting GnRH agonists
I M Spitz, B Chertin, A Fridmans, A Farkas, A Belanger, H Hartman and F Labrie
Abstract: http://links.ealert.nature.com/ctt?kn=31&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=86&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
---------------------------------------------------------------------
Are you looking to reach a highly-skilled market for your recruitment
or classified ads?
Nature Publishing Group can offer you a portfolio of prestigious journals
that are targeted down to a specific sub-specialization. With over 40
specialist titles to choose from, you can attract a highly-skilled
targeted audience within a number of scientific disciplines. Both print
and online options are available.
Contact your Naturejobs regional representative today:
W: http://links.ealert.nature.com/ctt?kn=89&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
E: naturejobs@nature.com
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=15&m=31328233&r=MTc2ODQ1OTU4MwS2&b=2&j=NDU2ODQxMzQS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
